Award
National Heart, Lung, and Blood Institute 2R01HL156021-06
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
Recipient
Vanderbilt University Medical Center
Award Amount
$849,674.00
Ceiling
$849,674.00
Awarded
July 08, 2026
Identifier
2R01HL156021-06
This NIH grant supports research on the immunologic and antigenic factors driving myocarditis linked to immune checkpoint inhibitors, led by Vanderbilt University Medical Center researchers.
Description
The project focuses on the immunologic and antigenic drivers of myocarditis associated with immune checkpoint inhibitors. The project involves multiple aims including evaluating thymic involution, tumor microenvironment, and mechanisms of cardiomyocyte death. The project is led by Justin M Balko, Professor, and Javid J Moslehi, Cardiologist. The project is funded by the National Heart Lung and Blood Institute (NHLBI) under the NIH.